Exicure (XCUR) Retained Earnings (2016 - 2026)
Exicure (XCUR) reported Retained Earnings of -$206.0 million for Q1 2026, down 4.99% on a YoY basis from -$216.8 million in Q1 2025, and down 0.9% quarter-over-quarter from -$204.2 million in Q4 2025.
Exicure (XCUR) Retained Earnings (2016 - 2026) Analysis & Trends
Exicure has reported Retained Earnings for 11 years, with the latest figure at -$206.0 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 4.99% year-over-year to -$206.0 million; the trailing twelve-month figure through Mar 2026 stood at -$206.0 million (down 4.99% YoY), and the FY2025 full-year result was -$204.2 million, down 2.48% from the prior year.
- Retained Earnings for Q1 2026 stood at -$206.0 million, down from -$204.2 million in the prior quarter.
- The five-year high for Retained Earnings was $102000.0 in Q3 2025, with the low at -$206.0 million in Q1 2026.
- Historically, Retained Earnings has averaged -$179.0 million across 5 years, with a median of -$190.4 million in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 8632350.0% — and 2025, when it surged 100.05%.
- Exicure's Retained Earnings stood at -$172.6 million in 2022, then retreated by 9.8% to -$189.6 million in 2023, then retreated by 5.12% to -$199.3 million in 2024, then fell by 2.48% to -$204.2 million in 2025, then declined by 0.9% to -$206.0 million in 2026.
- The last three Retained Earnings figures came in at -$206.0 million (Q1 2026), -$204.2 million (Q4 2025), and $102000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | -206.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.04 Mn |
| Dec 31, 2025 | -204.21 Mn |
| Sep 30, 2025 | 102,000.00 |
| Jun 30, 2025 | -198.88 Mn |
| Mar 31, 2025 | -196.25 Mn |
| Dec 31, 2024 | -199.26 Mn |
| Sep 30, 2024 | -192.08 Mn |
| Jun 30, 2024 | -190.99 Mn |
| Mar 31, 2024 | -190.39 Mn |
| Dec 31, 2023 | -189.56 Mn |
| Sep 30, 2023 | -188.08 Mn |
| Jun 30, 2023 | -182.82 Mn |
| Mar 31, 2023 | -177.06 Mn |
| Dec 31, 2022 | -172.65 Mn |
| Sep 30, 2022 | -191.05 Mn |
| Jun 30, 2022 | -185.89 Mn |
| Mar 31, 2022 | -178.42 Mn |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -156.24 Mn |
| Jun 30, 2021 | -132.71 Mn |